Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Altaco-XXI is a prominent Ukrainian pharmaceutical company specializing in the marketing, distribution, and promotion of medicinal products, medical devices, and dietary supplements. Established in 1997, the company serves as a strategic partner for international pharmaceutical manufacturers seeking to enter or expand within the Ukrainian market. Their comprehensive service suite includes regulatory support, pharmacovigilance, and large-scale logistics management. The company's portfolio features a variety of well-known brands across therapeutic areas such as gastroenterology, respiratory health, and otorhinolaryngology. Altaco-XXI operates an extensive distribution network, ensuring that high-quality healthcare products are accessible to pharmacies and medical institutions throughout Ukraine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ALTACO-XXI.